These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 36722655
1. Molecular basis of the different effects of procainamide and N-acetylprocainamide on the maximum upstroke velocity and half-decay time of the cardiac action potential in guinea pig papillary muscle. Sigler W, Oliveira AC. Braz J Med Biol Res; 2023; 56():e12073. PubMed ID: 36722655 [Abstract] [Full Text] [Related]
2. Electrophysiologic interactions of procainamide and N-acetylprocainamide in isolated canine cardiac Purkinje fibers. Coyle JD, Carnes CA, Schaal SF, Muir WW. J Cardiovasc Pharmacol; 1992 Aug; 20(2):197-205. PubMed ID: 1381010 [Abstract] [Full Text] [Related]
3. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide. Atkinson AJ, Ruo TI, Piergies AA. Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345 [Abstract] [Full Text] [Related]
9. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues. Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP. Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar 01; 355(3):398-405. PubMed ID: 9089672 [Abstract] [Full Text] [Related]
17. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships. Boucher M, Dubray C, Paire M, Duchêne-Marullaz P. J Cardiovasc Pharmacol; 1987 Nov 01; 10(5):562-7. PubMed ID: 2447406 [Abstract] [Full Text] [Related]